Severe sepsis and septic shock by Escherichia coli, clinical and microbiological analysis in Medellin, Colombia

被引:6
作者
Restrepo-Alvarez, Camilo A. [1 ]
Bernal, Elisa [1 ]
Ascuntar-Tello, Johana [1 ]
Jaimes, Fabian [1 ,2 ]
机构
[1] Univ Antioquia, Medellin, Colombia
[2] Hosp Univ San Vicente Fdn, Direcc Invest, Medellin, Colombia
来源
REVISTA CHILENA DE INFECTOLOGIA | 2019年 / 36卷 / 04期
关键词
Sepsis; septic shock; urinary tract infections; mortality; Escherichia coli; BLOOD-STREAM INFECTIONS; SERUM LACTATE; EMERGENCY-DEPARTMENT; EPIDEMIOLOGY; BACTEREMIA; MORTALITY; PREDICTOR; HOSPITALS;
D O I
10.4067/S0716-10182019000400447
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Escherichia coli is a common cause of a broad spectrum of infections, from non-complicated urinary tract infection, to severe sepsis and septic shock, that are associated to high impact outcomes, such as ICU admission and mortality. Aims: To establish differences in mortality, ICU admission, ESBL positive strains and antibiotic treatment, between patients with E. coli related severe sepsis and septic shock, with or without bacteremia and its variability based on the source of infection. Method: Secondary data analysis of a multicentric prospective cohort study. Results: From 458 patients with E. coli isolation, 123 had E. coli exclusively in blood culture, 222 solely in urine culture, and 113 in both samples. Escherichia coli isolation exclusively in blood culture was associated with higher frequency of ICU admission (n = 63; 51.2%), higher rate of mechanical ventilation requirement (n = 19; 15.5%), higher mortality and longer hospital stay (n = 22; 18%; median of 12 days, IQR= 7 - 17, respectively); but with a lower occurrence of ESBL strains, compared to patients with positive urine culture and positive blood/urine cultures (n = 20; 17.7% and n = 46; 20.7%, respectively). 424 patients (92.6%) received antibiotic treatment in the first 24 hours. The most commonly prescribed was piperacilin/tazobactam (n = 256; 60.3%). The proportion of patients empirically treated with carbapenems vs non-carbapenems was similar in the three groups. Discussion: The source of infection, associated with ESBL strains risk factors, are useful tools to define prognosis and treatment in this population, because of their clinical and microbiological variability. Conclusion: Patients with E. coli isolation exclusively in the blood culture had higher frequency of non-favorable outcomes in comparison to patients with E. coli in urine culture with or without bacteremia. Additionally, in our population patients with E. coli solely in blood culture have lower prevalence of ESBL positive strains.
引用
收藏
页码:447 / 454
页数:8
相关论文
共 28 条
  • [1] Artico MJ, 2012, REV ARGENT MICROBIOL, V44, P10, DOI 10.1590/S0325-75412012000100003
  • [2] Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
    Carlier, Mieke
    Carrette, Sofie
    Roberts, Jason A.
    Stove, Veronique
    Verstraete, Alain
    Hoste, Eric
    Depuydt, Pieter
    Decruyenaere, Johan
    Lipman, Jeffrey
    Wallis, Steven C.
    De Waele, Jan J.
    [J]. CRITICAL CARE, 2013, 17 (03):
  • [3] Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae
    Chaubey V.P.
    Pitout J.D.D.
    Dalton B.
    Ross T.
    Church D.L.
    Gregson D.B.
    Laupland K.B.
    [J]. BMC Research Notes, 3 (1)
  • [4] De La Rosa G, 2016, REV CHIL INFECTOL, V33, P141, DOI 10.4067/S0716-10182016000200003
  • [5] DELLINGER RP, 2013, INTENS CARE MED, V39, P165, DOI DOI 10.1007/s00134-012-2769-8
  • [6] Epidemiology and outcome of nosocomial and community-onset bloodstream infection
    Diekema, DJ
    Beekmann, SE
    Chapin, KC
    Morel, KA
    Munson, E
    Doern, GV
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) : 3655 - 3660
  • [7] Urosepsis-Etiology, Diagnosis, and Treatment
    Dreger, Nici Markus
    Degener, Stephan
    Ahmad-Nejad, Parviz
    Woebker, Gabriele
    Roth, Stephan
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (49): : 837 - +
  • [8] CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
    Horan, Teresa C.
    Andrus, Mary
    Dudeck, Margaret A.
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2008, 36 (05) : 309 - 332
  • [9] Antibiotics for the critically ill: more than just selecting appropriate initial therapy
    Kollef, Marin H.
    [J]. CRITICAL CARE, 2013, 17 (03)
  • [10] Levy Mitchell M, 2003, Intensive Care Med, V29, P530